Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial
Autor*in: |
Giamarellos-Bourboulis, E [verfasserIn] Lymberopoulou, K [verfasserIn] Tsangaris, I [verfasserIn] Antonopoulou, A [verfasserIn] Marioli, A [verfasserIn] Leonidou, L [verfasserIn] Douzinas, E [verfasserIn] Koutelidakis, I [verfasserIn] Armaganidis, A [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
---|
Übergeordnetes Werk: |
Enthalten in: Critical care - BioMed Central, 1997, 18(2014), Suppl 1 vom: 17. März |
---|---|
Übergeordnetes Werk: |
volume:18 ; year:2014 ; number:Suppl 1 ; day:17 ; month:03 |
Links: |
---|
DOI / URN: |
10.1186/cc13432 |
---|
Katalog-ID: |
SPR029877369 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR029877369 | ||
003 | DE-627 | ||
005 | 20240426065128.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/cc13432 |2 doi | |
035 | |a (DE-627)SPR029877369 | ||
035 | |a (SPR)cc13432-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Giamarellos-Bourboulis, E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( | ||
650 | 4 | |a Septic Shock |7 (dpeaa)DE-He213 | |
650 | 4 | |a Acute Lung Injury |7 (dpeaa)DE-He213 | |
650 | 4 | |a Clarithromycin |7 (dpeaa)DE-He213 | |
650 | 4 | |a Organ Dysfunction |7 (dpeaa)DE-He213 | |
650 | 4 | |a Metabolic Acidosis |7 (dpeaa)DE-He213 | |
700 | 1 | |a Lymberopoulou, K |e verfasserin |4 aut | |
700 | 1 | |a Tsangaris, I |e verfasserin |4 aut | |
700 | 1 | |a Antonopoulou, A |e verfasserin |4 aut | |
700 | 1 | |a Marioli, A |e verfasserin |4 aut | |
700 | 1 | |a Leonidou, L |e verfasserin |4 aut | |
700 | 1 | |a Douzinas, E |e verfasserin |4 aut | |
700 | 1 | |a Koutelidakis, I |e verfasserin |4 aut | |
700 | 1 | |a Armaganidis, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Critical care |d BioMed Central, 1997 |g 18(2014), Suppl 1 vom: 17. März |w (DE-627)331258269 |w (DE-600)2051256-9 |x 1364-8535 |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2014 |g number:Suppl 1 |g day:17 |g month:03 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/cc13432 |m X:SPRINGER |x Resolving-System |z lizenzpflichtig |3 Volltext |
912 | |a SYSFLAG_0 | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
936 | b | k | |a 44.00 |q VZ |
951 | |a AR | ||
952 | |d 18 |j 2014 |e Suppl 1 |b 17 |c 03 |
author_variant |
e g b egb k l kl i t it a a aa a m am l l ll e d ed i k ik a a aa |
---|---|
matchkey_str |
article:13648535:2014----::fetflrtrmcnnainsihrmeaieessugopnl |
hierarchy_sort_str |
2014 |
bklnumber |
44.00 |
publishDate |
2014 |
allfields |
10.1186/cc13432 doi (DE-627)SPR029877369 (SPR)cc13432-e DE-627 ger DE-627 rakwb eng 610 VZ 44.00 bkl Giamarellos-Bourboulis, E verfasserin aut Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 Lymberopoulou, K verfasserin aut Tsangaris, I verfasserin aut Antonopoulou, A verfasserin aut Marioli, A verfasserin aut Leonidou, L verfasserin aut Douzinas, E verfasserin aut Koutelidakis, I verfasserin aut Armaganidis, A verfasserin aut Enthalten in Critical care BioMed Central, 1997 18(2014), Suppl 1 vom: 17. März (DE-627)331258269 (DE-600)2051256-9 1364-8535 nnns volume:18 year:2014 number:Suppl 1 day:17 month:03 https://dx.doi.org/10.1186/cc13432 X:SPRINGER Resolving-System lizenzpflichtig Volltext SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 44.00 VZ AR 18 2014 Suppl 1 17 03 |
spelling |
10.1186/cc13432 doi (DE-627)SPR029877369 (SPR)cc13432-e DE-627 ger DE-627 rakwb eng 610 VZ 44.00 bkl Giamarellos-Bourboulis, E verfasserin aut Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 Lymberopoulou, K verfasserin aut Tsangaris, I verfasserin aut Antonopoulou, A verfasserin aut Marioli, A verfasserin aut Leonidou, L verfasserin aut Douzinas, E verfasserin aut Koutelidakis, I verfasserin aut Armaganidis, A verfasserin aut Enthalten in Critical care BioMed Central, 1997 18(2014), Suppl 1 vom: 17. März (DE-627)331258269 (DE-600)2051256-9 1364-8535 nnns volume:18 year:2014 number:Suppl 1 day:17 month:03 https://dx.doi.org/10.1186/cc13432 X:SPRINGER Resolving-System lizenzpflichtig Volltext SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 44.00 VZ AR 18 2014 Suppl 1 17 03 |
allfields_unstemmed |
10.1186/cc13432 doi (DE-627)SPR029877369 (SPR)cc13432-e DE-627 ger DE-627 rakwb eng 610 VZ 44.00 bkl Giamarellos-Bourboulis, E verfasserin aut Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 Lymberopoulou, K verfasserin aut Tsangaris, I verfasserin aut Antonopoulou, A verfasserin aut Marioli, A verfasserin aut Leonidou, L verfasserin aut Douzinas, E verfasserin aut Koutelidakis, I verfasserin aut Armaganidis, A verfasserin aut Enthalten in Critical care BioMed Central, 1997 18(2014), Suppl 1 vom: 17. März (DE-627)331258269 (DE-600)2051256-9 1364-8535 nnns volume:18 year:2014 number:Suppl 1 day:17 month:03 https://dx.doi.org/10.1186/cc13432 X:SPRINGER Resolving-System lizenzpflichtig Volltext SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 44.00 VZ AR 18 2014 Suppl 1 17 03 |
allfieldsGer |
10.1186/cc13432 doi (DE-627)SPR029877369 (SPR)cc13432-e DE-627 ger DE-627 rakwb eng 610 VZ 44.00 bkl Giamarellos-Bourboulis, E verfasserin aut Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 Lymberopoulou, K verfasserin aut Tsangaris, I verfasserin aut Antonopoulou, A verfasserin aut Marioli, A verfasserin aut Leonidou, L verfasserin aut Douzinas, E verfasserin aut Koutelidakis, I verfasserin aut Armaganidis, A verfasserin aut Enthalten in Critical care BioMed Central, 1997 18(2014), Suppl 1 vom: 17. März (DE-627)331258269 (DE-600)2051256-9 1364-8535 nnns volume:18 year:2014 number:Suppl 1 day:17 month:03 https://dx.doi.org/10.1186/cc13432 X:SPRINGER Resolving-System lizenzpflichtig Volltext SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 44.00 VZ AR 18 2014 Suppl 1 17 03 |
allfieldsSound |
10.1186/cc13432 doi (DE-627)SPR029877369 (SPR)cc13432-e DE-627 ger DE-627 rakwb eng 610 VZ 44.00 bkl Giamarellos-Bourboulis, E verfasserin aut Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 Lymberopoulou, K verfasserin aut Tsangaris, I verfasserin aut Antonopoulou, A verfasserin aut Marioli, A verfasserin aut Leonidou, L verfasserin aut Douzinas, E verfasserin aut Koutelidakis, I verfasserin aut Armaganidis, A verfasserin aut Enthalten in Critical care BioMed Central, 1997 18(2014), Suppl 1 vom: 17. März (DE-627)331258269 (DE-600)2051256-9 1364-8535 nnns volume:18 year:2014 number:Suppl 1 day:17 month:03 https://dx.doi.org/10.1186/cc13432 X:SPRINGER Resolving-System lizenzpflichtig Volltext SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 44.00 VZ AR 18 2014 Suppl 1 17 03 |
language |
English |
source |
Enthalten in Critical care 18(2014), Suppl 1 vom: 17. März volume:18 year:2014 number:Suppl 1 day:17 month:03 |
sourceStr |
Enthalten in Critical care 18(2014), Suppl 1 vom: 17. März volume:18 year:2014 number:Suppl 1 day:17 month:03 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Septic Shock Acute Lung Injury Clarithromycin Organ Dysfunction Metabolic Acidosis |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Critical care |
authorswithroles_txt_mv |
Giamarellos-Bourboulis, E @@aut@@ Lymberopoulou, K @@aut@@ Tsangaris, I @@aut@@ Antonopoulou, A @@aut@@ Marioli, A @@aut@@ Leonidou, L @@aut@@ Douzinas, E @@aut@@ Koutelidakis, I @@aut@@ Armaganidis, A @@aut@@ |
publishDateDaySort_date |
2014-03-17T00:00:00Z |
hierarchy_top_id |
331258269 |
dewey-sort |
3610 |
id |
SPR029877369 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR029877369</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240426065128.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/cc13432</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR029877369</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)cc13432-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giamarellos-Bourboulis, E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Septic Shock</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Lung Injury</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clarithromycin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Organ Dysfunction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic Acidosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lymberopoulou, K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsangaris, I</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antonopoulou, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marioli, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leonidou, L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Douzinas, E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koutelidakis, I</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Armaganidis, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Critical care</subfield><subfield code="d">BioMed Central, 1997</subfield><subfield code="g">18(2014), Suppl 1 vom: 17. März</subfield><subfield code="w">(DE-627)331258269</subfield><subfield code="w">(DE-600)2051256-9</subfield><subfield code="x">1364-8535</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:17</subfield><subfield code="g">month:03</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/cc13432</subfield><subfield code="m">X:SPRINGER</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_0</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.00</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2014</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">17</subfield><subfield code="c">03</subfield></datafield></record></collection>
|
author |
Giamarellos-Bourboulis, E |
spellingShingle |
Giamarellos-Bourboulis, E ddc 610 bkl 44.00 misc Septic Shock misc Acute Lung Injury misc Clarithromycin misc Organ Dysfunction misc Metabolic Acidosis Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
authorStr |
Giamarellos-Bourboulis, E |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)331258269 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1364-8535 |
topic_title |
610 VZ 44.00 bkl Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial Septic Shock (dpeaa)DE-He213 Acute Lung Injury (dpeaa)DE-He213 Clarithromycin (dpeaa)DE-He213 Organ Dysfunction (dpeaa)DE-He213 Metabolic Acidosis (dpeaa)DE-He213 |
topic |
ddc 610 bkl 44.00 misc Septic Shock misc Acute Lung Injury misc Clarithromycin misc Organ Dysfunction misc Metabolic Acidosis |
topic_unstemmed |
ddc 610 bkl 44.00 misc Septic Shock misc Acute Lung Injury misc Clarithromycin misc Organ Dysfunction misc Metabolic Acidosis |
topic_browse |
ddc 610 bkl 44.00 misc Septic Shock misc Acute Lung Injury misc Clarithromycin misc Organ Dysfunction misc Metabolic Acidosis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Critical care |
hierarchy_parent_id |
331258269 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Critical care |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)331258269 (DE-600)2051256-9 |
title |
Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
ctrlnum |
(DE-627)SPR029877369 (SPR)cc13432-e |
title_full |
Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
author_sort |
Giamarellos-Bourboulis, E |
journal |
Critical care |
journalStr |
Critical care |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
txt |
author_browse |
Giamarellos-Bourboulis, E Lymberopoulou, K Tsangaris, I Antonopoulou, A Marioli, A Leonidou, L Douzinas, E Koutelidakis, I Armaganidis, A |
container_volume |
18 |
class |
610 VZ 44.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Giamarellos-Bourboulis, E |
doi_str_mv |
10.1186/cc13432 |
dewey-full |
610 |
author2-role |
verfasserin |
title_sort |
effect of clarithromycin in patients with gram-negative sepsis: subgroup analysis of a randomized trial |
title_auth |
Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
abstract |
© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
abstractGer |
© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
abstract_unstemmed |
© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
collection_details |
SYSFLAG_0 GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
Suppl 1 |
title_short |
Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial |
url |
https://dx.doi.org/10.1186/cc13432 |
remote_bool |
true |
author2 |
Lymberopoulou, K Tsangaris, I Antonopoulou, A Marioli, A Leonidou, L Douzinas, E Koutelidakis, I Armaganidis, A |
author2Str |
Lymberopoulou, K Tsangaris, I Antonopoulou, A Marioli, A Leonidou, L Douzinas, E Koutelidakis, I Armaganidis, A |
ppnlink |
331258269 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1186/cc13432 |
up_date |
2024-07-04T02:34:15.426Z |
_version_ |
1803614112108773376 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR029877369</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240426065128.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/cc13432</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR029877369</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)cc13432-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giamarellos-Bourboulis, E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of clarithromycin in patients with Gram-negative sepsis: subgroup analysis of a randomized trial</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd. 2014. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Septic Shock</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Lung Injury</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clarithromycin</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Organ Dysfunction</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic Acidosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lymberopoulou, K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsangaris, I</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antonopoulou, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marioli, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leonidou, L</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Douzinas, E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koutelidakis, I</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Armaganidis, A</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Critical care</subfield><subfield code="d">BioMed Central, 1997</subfield><subfield code="g">18(2014), Suppl 1 vom: 17. März</subfield><subfield code="w">(DE-627)331258269</subfield><subfield code="w">(DE-600)2051256-9</subfield><subfield code="x">1364-8535</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:17</subfield><subfield code="g">month:03</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/cc13432</subfield><subfield code="m">X:SPRINGER</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_0</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.00</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2014</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">17</subfield><subfield code="c">03</subfield></datafield></record></collection>
|
score |
7.4011545 |